Search - tctmd.com

Displaying 381 - 400 of 8267

Sort: Relevancy | Date

Presentation THT 2025

Safety and Efficacy of the preCARDIA System to Mechanically Reduce Cardiac Preload for Acutely Decompensated Heart Failure: The Expanded VENoUS Heart Failure (VENUS-HF) Early Feasibility Study

Presenter: Navin Kapur

February 12, 2025

Presentation THT Abstracts 2025

Heart Failure Management Using a Risk Score From an Insertable Cardiac Monitor: The Rationale and Design of the ALLEVIATE-HF Trial

Presenter: Javed Butler

February 11, 2025

Presentation THT Abstracts 2025

Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Use in Cardiac Sarcoidosis Cardiomyopathy

Presenter: Ahmed Mahmoud

February 11, 2025

Presentation THT Abstracts 2025

The Use of Cardiac Contractility Modulation(CCM) and Durable Left Ventricular Assist Device (LVAD) for Patients With Class IV CHF

Presenter: Kanika Mody

February 11, 2025

Presentation THT Abstracts 2025

Congestive Cardiac Failure Mortality in the United States: Trends and Disparities From 1999 to 2020

Presenter: Sherif Eltawansy

February 11, 2025

Presentation THT Abstracts 2025

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Presenter: Alexis Barnes

February 11, 2025

Presentation THT Abstracts 2025

Association of Temporary Mechanical Circulatory Support With Allosensitization and Cardiac Transplant Outcomes

Presenter: Jason Feinman

February 11, 2025

News Daily News

PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent

L.A. McKeown

February 11, 2025

Presentation THT 2025

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Presenter: Alexis Barnes

February 11, 2025

Presentation THT 2025

Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Use in Cardiac Sarcoidosis Cardiomyopathy

Presenter: Ahmed Mahmoud

February 11, 2025

Presentation THT 2025

Heart Failure Management Using a Risk Score From an Insertable Cardiac Monitor: The Rationale and Design of the ALLEVIATE-HF Trial

Presenter: Javed Butler

February 11, 2025

Presentation THT 2025

Management of Clinically Stable Patients With Impella 5.5 on a Cardiac Stepdown Unit Is Associated With Low Adverse Event Rates and Lower Hospital Costs

Presenter: Anthony Carnicelli

February 11, 2025

Presentation THT 2025

Association of Temporary Mechanical Circulatory Support With Allosensitization and Cardiac Transplant Outcomes

Presenter: Jason Feinman

February 11, 2025

Presentation THT 2025

Cardiac Microcurrent Application for the Reversal of Heart Failure

Presenter: Eduardo Rame

February 11, 2025

Presentation THT 2025

Duration of Heart Failure, Cardiac Dysfunction and Remodeling, and Response to Atrial Shunt Treatment in HFpEF and HFmrEF

Presenter: Barry Borlaug

February 11, 2025

Presentation THT 2025

Future Cardia

Presenter: Marat Fudim

February 11, 2025

Presentation THT 2025

Current Evidence for Cardiac Myosin Inhibitors: Where Are We in 2025?

Presenter: Martin Maron

February 11, 2025

Presentation THT 2025

The Percutaneous Synchronized Cardiac Assist (PSCA) System for Extravascular Mechanical Circulatory Support: A Safety and Hemodynamic Performance Study

Presenter: Petr Neuzil

February 11, 2025

Presentation THT 2025

Optimizing Outcomes in Cardiac Arrest and Shock

Presenter: Jacqueline Tamis-Holland

February 11, 2025

Presentation THT 2025

Novel Therapies for AL Cardiac Amyloidosis – Bi-Specific Antibodies, BCL Inhibitors and More

Presenter: Giada Bianchi

February 11, 2025

Advertisement

Safety and Efficacy of the preCARDIA System to Mechanically Reduce Cardiac Preload for Acutely Decompensated Heart Failure: The Expanded VENoUS Heart Failure (VENUS-HF) Early Feasibility Study

Heart Failure Management Using a Risk Score From an Insertable Cardiac Monitor: The Rationale and Design of the ALLEVIATE-HF Trial

Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Use in Cardiac Sarcoidosis Cardiomyopathy

The Use of Cardiac Contractility Modulation(CCM) and Durable Left Ventricular Assist Device (LVAD) for Patients With Class IV CHF

Congestive Cardiac Failure Mortality in the United States: Trends and Disparities From 1999 to 2020

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Association of Temporary Mechanical Circulatory Support With Allosensitization and Cardiac Transplant Outcomes

PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Use in Cardiac Sarcoidosis Cardiomyopathy

Heart Failure Management Using a Risk Score From an Insertable Cardiac Monitor: The Rationale and Design of the ALLEVIATE-HF Trial

Management of Clinically Stable Patients With Impella 5.5 on a Cardiac Stepdown Unit Is Associated With Low Adverse Event Rates and Lower Hospital Costs

Association of Temporary Mechanical Circulatory Support With Allosensitization and Cardiac Transplant Outcomes

Cardiac Microcurrent Application for the Reversal of Heart Failure

Duration of Heart Failure, Cardiac Dysfunction and Remodeling, and Response to Atrial Shunt Treatment in HFpEF and HFmrEF

Future Cardia

Current Evidence for Cardiac Myosin Inhibitors: Where Are We in 2025?

The Percutaneous Synchronized Cardiac Assist (PSCA) System for Extravascular Mechanical Circulatory Support: A Safety and Hemodynamic Performance Study

Optimizing Outcomes in Cardiac Arrest and Shock

Novel Therapies for AL Cardiac Amyloidosis – Bi-Specific Antibodies, BCL Inhibitors and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content